VicSIS 更新 - 服务已更改

从 2022 年 7 月起,VicSIS(维多利亚专家免疫服务网络)提供的服务发生了变化。 VicSIS 诊所的数量及其地点已经减少,成人服务现在仅在 Barwon Health、Austin Health、Monash Health 和 Peter MacCallum 癌症中心提供。由于这些变化,预约的等待时间可能会更长,因此应告知患者。 

此外,VicSIS 不再资助支持儿科 COVID-19 疫苗接种。需要专家建议的 15 岁及以下儿童可以通过皇家儿童医院和莫纳什健康中心现有的专家免疫诊所进行检查。这些服务的推荐应继续通过 VicSIS eReferral 门户提交。 

有关 VicSIS 的更多信息,请参阅以下链接: 

MVEC:维克西斯 


ATAGI 更新了冬季剂量 COVID-19 疫苗的建议

ATAGI 扩大了推荐接受 COVID-19 冬季加强剂量的人群,现在包括:  

  • 任何 50 岁及以上的成年人(包括原住民和托雷斯海峡岛民)   
  • 16 岁及以上的老年护理或残疾护理居民   
  • 16 岁及以上患有严重疾病的人 免疫功能低下, 残疾或复杂的健康需求,或患有多种合并症的人,这可能会增加较差结果的可能性。  

此外,任何希望降低 COVID-19 感染可能性的 30-49 岁成年人也可以接受冬季加强剂量。之前 COVID-19 感染或之前加强剂量与冬季加强剂量之间的推荐间隔为 3 个月。 

ATAGI 关切地注意到,加强剂量的覆盖范围(第一剂和冬季剂)对符合条件的人群来说并不理想,并强调了疫苗接种在预防严重感染和住院方面的重要性。  

要完整阅读更新后的建议,请单击以下链接:

ATAGI 更新了冬季剂量 COVID-19 疫苗的建议


新的免疫参考页:伤寒

伤寒和副伤寒是细菌感染,统称为肠热,由肠杆菌亚种血清型伤寒和副伤寒 A、B 和 C 引起。症状从轻微到严重不等,如果不及时治疗,可能会导致严重的并发症甚至死亡.它们可能包括长时间发烧、腹部症状或菌血症(血液中的细菌)。

我们新的参考页面概述了伤寒的症状和体征、传播途径和流行病学,以及前往伤寒流行地区旅行时可用于疾病预防的疫苗。

要阅读更多信息,请点击以下链接:
MVEC:伤寒


New immunisation reference page: Mandatory vaccine directions in Victoria

A vaccine mandate means that proof of vaccination, or an authorised medical exemption, is required in certain settings. In our new reference page, we provide information on the vaccine mandates affecting Victorians, including COVID-19 and influenza directions and “No jab, no play” and “No jab, no pay” legislations. Also included is information on the responsibility of the employee/service provider/individual and medical exemptions.  

For further information, click on the link below: 

MVEC: Mandatory vaccine direction in Victoria


Save the date for MVEC’s Immunisation Skills Workshop – Friday 2 September 2022

MVEC are pleased to invite you to save the date for our 免疫技能研讨会 taking place on Friday 2nd September. 

The full day interactive, face-to-face workshop is MVEC’s newest learning opportunity designed to provide education and upskilling in the principles and processes of managing: 

  • 有效的疫苗沟通 
  • 错误预防和管理 
  • anaphylaxis and acute stress responses 

Participants will hear from immunisation experts and have the opportunity to engage in simulated scenarios. 

The workshop will account for 12 nursing CPD hours and up to 24 points of CPD for pharmacist immunisers (including preparation and reading time). 

Further program details and a link to register will be available via our 活动页面 soon. 


NCIRS resource now available – Influenza vaccination coverage data

NCIRS have published a report outlining influenza vaccination coverage according to state/territory as well as age group, in Australia in 2022. Rates are compared to vaccination coverage reported in 2020 and 2021. This report will be updated weekly and uses data obtained from the Australian Immunisation Register.  

Influenza vaccines are recommended for all people aged ≥ 6 months. They are provided for free on the National Immunisation Program (NIP) for at-risk groups including children under 5, people with specific medical risk factors, pregnant women, people aged 65 and over and all Aboriginal and Torres Strait Islanders aged ≥ 6 months. Some individual jurisdictions are also providing free flu vaccination for all aged ≥ 6 months. Any other individuals who are unable to source a funded vaccine can obtain a flu vaccine for a small fee.  

As of the 11 June 2022, 31.6% of Australians aged 6 months and above had received an influenza vaccination, and just 20.2% of Aboriginal and Torres Strait Islander Peoples had received one.  

To view the NCIRS data, please click on the link below.
NCIRS Influenza vaccination coverage data 

For more information on influenza vaccines, please click on the link below. 
MVEC: Influenza recommendations


New resource for seniors added to the MVEC immunisation hub for the general public

Due to the immune system becoming less effective as we age and the increasing risk of severe disease, immunisation is an important aspect of health promotion for seniors.  

Our dedicated immunisation resource includes information for seniors on vaccine preventable diseases, vaccine recommendations, answers to frequently asked questions and links to further resources. 

MVEC’s hub of up-to-date and reliable information aims to increase the public’s awareness and understanding of vaccine preventable diseases and promote the benefits of immunisation for people of all ages. 

If you are interested in collaborating with MVEC to develop immunisation resources, we’d love to hear from you! 

To access this new resource for seniors, please click on the link below:  

Resource for seniors: MVEC’s new Immunisation hub for the general public

 


ATAGI recommendations on first booster dose in adolescents aged 12-15 years

ATAGI has provided updated advice regarding COVID-19 booster doses for those aged 12-15 years. 

A single booster dose of Comirnaty (Pfizer) is now recommended for the following select groups:  

  • those who are severely immunocompromised 
  • those who have a disability with significant or complex health needs 
  • those who have complex and/or multiple health conditions that increase the risk of severe COVID-19. 

Booster doses can be administered ≥ 3 months after the completion of the primary course, or ≥ 3 months after COVID-19 infection (whichever is later).  

There is currently insufficient evidence to support expanding this booster dose recommendation to other groups of adolescents aged 12-15 years, however this advice may change in the future as more evidence emerges.  

要完整阅读建议,请点击以下链接。    

ATAGI recommendations on first booster dose in adolescents aged 12-15 years 


Updated MVEC immunisation reference page: Kawasaki disease and immunisation

MVEC’s reference page on 川崎病与免疫 has recently been updated. This resource outlines:  

  • what Kawasaki disease is 
  • vaccine recommendations for providers 
  • specific precautions to take when vaccinating 

要查看完整页面,请点击以下链接: 

MVEC: Kawasaki disease and immunisation 


ABC Radio Canberra with A/Prof Nigel Crawford: Influenza and the importance of the flu vaccine for children under five.

MVEC’s Associate Professor Nigel Crawford was interviewed by ABC Radio Canberra to discuss influenza in children under five. With younger children at greater risk of contracting severe disease, A/Prof Crawford explains the importance of vaccinating children every flu season to ensure the best protection. 

You can listen to the interview here:
ABC Radio Canberra: Influenza and the importance of the flu vaccine for children under five.


关于 MVEC

墨尔本疫苗教育中心 (MVEC) 是一个教育网站,旨在为医疗保健专业人员和公众提供最新的免疫接种信息。我们位于研究机构默多克儿童研究所 (MCRI),隶属于维多利亚疫苗安全服务机构 SAEFVIC(社区接种疫苗后的不良事件监测)。